Vaccines

Scientists opposed to offering booster shots to all Americans said data provided by federal health officials wasn’t compelling enough to support the recommendation — some argued boosters could lead to more vaccine-resistant variants.

Things are not going well in Australia. The once ostensibly democratic country has been the scene of some of the strictest, most irrational lockdown policies of the entire pandemic. And while their neighbor, New Zealand, has gone absolutely insane (including locking down over a single COVID case), the Aussies are right there with them.

Those who caught the Delta Variant of the CCP virus after being fully vaccinated carry a similar level of peak viral burden with their unvaccinated counterparts, a new UK analysis suggests.

The government has a history of shamelessly exploiting national emergencies for its own nefarious purposes. Terrorist attacks, mass shootings, civil unrest, economic instability, pandemics, natural disasters: the government has been taking advantage of such crises for years now in order to gain greater power over an unsuspecting and largely gullible populace.

Data released today by the Centers for Disease Control and Prevention (CDC) showed that between Dec. 14, 2020 and Aug. 13, 2021, a total of 595,622 total adverse events were reported to VAERS, including 13,068 deaths — an increase of 702 over the previous week.

As the chaos in Afghanistan unfolded, people around the world were clamoring to hear from President Biden, who was on vacation at Camp David.

"That sounds to me like a money-making operation for Pfizer."

At least 30,304 British women have disclosed changes to their menstrual cycle after getting vaccinated against Covid-19. An editor for The Spectator is one of the most recently affected, and says many more are afraid to come out.

The Centers for Disease Control and Prevention Wednesday released three studies on the effectiveness of the Pfizer and Moderna vaccines. A UK study released Tuesday showed people with "breakthrough" infections carry as much virus as the unvaccinated.

The U.S. Defense Advanced Research Projects Agency (DARPA) awarded the gene-based vaccine developer $25.3 million "to research and develop its messenger RNA therapeutics" nearly 8 years ago.